EverZom Secures €10 Million Financing Round for Development of Exosome-Based Therapies

Laura Testa Europe Legal Chronicle
Tagged:

McDermott Will & Schulte has advised EverZom.EverZom has completed a €10 million financing round to advance its work on innovative exosome-based therapies targeting inflammatory and regenerative…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here